Hospitals to put doctors' relationships with pharmaceutical companies under the microscope
The University of Colorado School of Medicine, National Jewish and Denver Health are all reviewing and tightening ethics rules as dozens of doctors defy reporting requirements for drug-company payments that can reach well into six figures.
National Jewish, most of whose doctors have dual roles with CU, said it is conducting its own rules review after a preliminary CU report said doctors were testing ethical boundaries and ignoring or disobeying disclosure rules.
"The status quo is no longer acceptable," said Richard Krugman, dean of the CU medical school.
Denver Health spokeswoman Dee Martinez said the hospital system is also reviewing its ethics policies for potential revision, given the recent outcry about pharmaceutical- company spending.
- CNO Leads $1M Charge for New Scrubs, Uniforms
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Transforming Cancer Care
- Acute Kidney Injury Gets New Focus
- Interventional Radiology No Longer a Sub-Specialty
- Sharp HealthCare Leaves Pioneer ACO Program
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- mHealth Tackles Readmissions
- MA an Insurance Proving Ground for Providers
- Proton Beam Therapy Poised for Growth in US